CME Outfitters Announces Live neuroscienceCME TV Activity: "Bipolar Depression: Individualizing Treatment to Prevent Relapse and Recurrence" Premieres Wed, Sept. 10, 2008
CME Outfitters announces an upcoming live and interactive neuroscienceCME TV activity titled "Bipolar Depression: Individualizing Treatment to Prevent Relapse and Recurrence." Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, September 10, 2008, from 12:00 p. m.-1:00 p. m. ET, the activity will incorporate the latest evidence-based diagnosis and treatment strategies to provide early detection, intervention, and long-term maintenance opportunities for improving outcomes for patients with bipolar depression.
Rockville, MD (PRWEB) July 10, 2008
CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME TV activity titled "Bipolar Depression: Individualizing Treatment to Prevent Relapse and Recurrence."
Premiering Wednesday, September 10, 2008, from 12 p. m.-1 p. m. ET, the activity will incorporate the latest evidence-based diagnosis and treatment strategies to provide early detection, intervention, and long-term maintenance opportunities for improving outcomes for patients with bipolar depression. This activity also includes a special "After the Show" segment during which the faculty answers additional audience questions in an informal Q&A session. The recorded satellite broadcast will re-air from 3:00 p. m.-4:00 p. m. ET. This CE activity will also be available as an archived webcast, podcast, and telephone audioconference shortly after the broadcast premiere, and available as a multimedia CD-ROM in October 2008.
There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www. neuroscienceCME. com/PR320 (http://www. neuroscienceCME. com/PR320) and click the Register icon.
Phone: Call 877.CME. PROS (877.263.7767).
Fax: Visit the activity details page at http://www. neuroscienceCME. com/PR320 (http://www. neuroscienceCME. com/PR320), print and complete the activity details form, and fax to 240.243.1033.
Statement of Need:
There is an unmet need for maintenance pharmacologic treatments that target bipolar depression. Despite the preponderance of depressive symptoms and episodes (versus manic) over the course of both bipolar I and II disorder, and the more frequent functional impairment associated with bipolar depression, there has been a disproportionate lack of attention paid to establishing effective management of bipolar depression. This has recently begun to change, however, with the approval and addition of atypical antipsychotics to the arsenal of medications used for bipolar depression. Recently completed studies and trials in progress are expected to contribute to the growing literature supporting the effectiveness of these types of medications for the treatment of bipolar depression. Clinicians are in urgent need of education and performance improvement in the recognition, diagnosis, and maintenance treatment of bipolar depression. Published treatment guidelines are an adequate framework for developing treatment plans. However, clinicians need additional education on pharmacologic treatments for bipolar depression. In this evidence-based, neuroscienceCME TV activity, experts will provide information on pharmacologic treatments for bipolar depression that will enable participants to integrate these findings into current treatment guidelines to further enhance and maintain good patient outcomes.
Moderator:
Mark A. Frye, MD
Professor of Psychiatry
Mayo Clinic
Director, The Mayo Mood Clinic and Research Program
Rochester, MN
Faculty:
Susan L. McElroy, MD
Chief of Research, Lindner Center of HOPE
Mason, OH
Professor of Psychiatry & Neuroscience
Department of Psychiatry
University of Cincinnati College of Medicine
Cincinnati, OH
Roger S. McIntyre, MD, FRCPC
Associate Professor of Psychiatry and Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
University Health Network
Toronto, ON
Learning Objectives:
At the end of this CE activity, participants should be able to:
Identify strategies for differential diagnosis of bipolar depression. Compare and contrast atypical antipsychotics with respect to efficacy, tolerability and other clinical factors important to the maintenance treatment of bipolar depression. Apply knowledge of mechanisms of action to the selection of treatments for bipolar depression, particularly with respect to the use of atypical antipsychotics. Formulate and implement treatment plans integrating latest evidence-based pharmacologic and psychosocial intervention strategies with available treatment guidelines.
Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals interested in mental health.
Commercial Support:
CME Outfitters, LLC, gratefully acknowledges an educational grant from AstraZeneca Pharmaceuticals in support of this CE activity.
Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
It has been assigned code 6WASUP-PRV-0639. 1.0 contact hours will be awarded upon successful completion.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.
CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)
NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.
CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-000-08-016-L01-P (live presentation) 376-000-08-016-H01-P (recorded programs)
Post-tests, credit request forms, and activity evaluations can be completed online at www. neuroscienceCME. com (click on the Testing/Certification link under the Resources tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.
About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com), http://www. neuroscienceCME. com (http://www. neuroscienceCME. com), or call 877.CME. PROS (877.263.7767).
About neuroscienceCME:
NeuroscienceCME. com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME. com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences.
About neuroscienceCME TV:
Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference, neuroscienceCME TV is a one-hour, live and interactive continuing education (CE) activity where leading experts discuss clinically relevant, evidence-based issues facing mental health practitioners. Each broadcast's interactivity is enhanced by offering a Q&A segment during which the faculty presenters can respond to audience comments and questions posed via e-mail, fax, or phone. CME Outfitters has also developed a web-based instant polling feature that allows live webcast participants a chance to provide real-time input. Online CE credit is offered to participants upon completion of each activity, at neuroscienceCME. com.
To view all recent neuroscienceCME press releases, visit http://www. neuroscienceCME. com (http://www. neuroscienceCME. com) and click on "News Room" or visit http://www. prweb. com (http://www. prweb. com) and search for "neuroscienceCME."
Clinical Compass™, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www. neuroscienceCME. com (http://www. neuroscienceCME. com) and click on "Subscribe to Clinical Compass™."
Contact: Jessica Primanzon
CME Outfitters, LLC
240.243.1308 direct
240.243.1033 fax
###
